During the past decade, Centre podiatrique et soins des plaies conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre podiatrique et soins des plaies" #1 collaborator was "Integrium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre podiatrique et soins des plaies" are "Diabetic Foot Ulcers" (3 trials) and "Venous Leg Ulcers" (1 trials). Many other conditions were trialed in "Centre podiatrique et soins des plaies" in a lesser frequency.

Most popular intervention types in "Centre podiatrique et soins des plaies" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DSC127" (1 trials), "Granexin gel" (1 trials), "PICO System" (1 trials), "Standard of Care gel, Aquasite" (1 trials) and "Vehicle gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre podiatrique et soins des plaies" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centre podiatrique et soins des plaies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre podiatrique et soins des plaies, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre podiatrique et soins des plaies, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".